Cerebral venous thrombosis: A review

Neurologist

Volumn 12, Issue 1, 2006, Pages 32-38

  Ehtisham, As'ad ^a,c   Stern, Barney J ^b  

^a EMORY UNIVERSITY HOSPITAL   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^c NONE   (United States)

Author keywords

Cerebral venous thrombosis (CVT); Hypercoagulable states; Intrasinus thrombolysis

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); ABCIXIMAB; ACTIVATED PROTEIN C; ALTEPLASE; ANTICOAGULANT AGENT; ANTICONVULSIVE AGENT; ANTITHROMBOCYTIC AGENT; ASPARAGINASE; BLOOD CLOTTING FACTOR 5 LEIDEN; FIBRINOGEN RECEPTOR ANTAGONIST; FIBRINOLYTIC AGENT; HEPARIN; HEPARIN DERIVATIVE; LOW MOLECULAR WEIGHT HEPARIN; MANNITOL; ORAL CONTRACEPTIVE AGENT; PHOSPHOLIPID ANTIBODY; PLASMINOGEN; PROTEIN S; PROTHROMBIN; SODIUM CHLORIDE; UROKINASE;

ARTERY THROMBOSIS; BLOOD CLOT LYSIS; CEREBROVASCULAR ACCIDENT; CLINICAL FEATURE; CONSCIOUSNESS DISORDER; CONTRACEPTION; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; ENDOVASCULAR SURGERY; FUNCTIONAL DISEASE; HEADACHE; HEMATOLOGIC DISEASE; HUMAN; HYPERCOAGULABILITY; INTRACRANIAL HYPERTENSION; INTRASINUS THROMBOLYSIS; LUNG EMBOLISM; MAJOR CLINICAL STUDY; NEUROLOGIC DISEASE; NEUROPATHOLOGY; OCCLUSIVE CEREBROVASCULAR DISEASE; ONSET AGE; PREGNANCY; PRIORITY JOURNAL; REVIEW; SEIZURE; STROKE; SYMPTOMATOLOGY; TREATMENT OUTCOME;

HUMANS; INTRACRANIAL THROMBOSIS; PROGNOSIS; VENOUS THROMBOSIS;

EID: 33646487620     PISSN: 10747931     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.nrl.0000178755.90391.b6     Document Type: Review

References (30)

1. Ehler H, CC. Thrombosis of internal cerebral vein in infancy and childhood: review of literature and reports of five cases. J Pediatr. 1936;8:600-623.
2. AT. The syndrome of latent cerebral venous thrombosis: its frequency and relation to age and congestive heart failure. Stroke. 1973;4:419-430.
3. Ameri A, BM. Cerebral venous thrombosis. Neurol Clin. 1992;10:87-111.
4. Bousser MG, RR. Cerebral Venous Thrombosis, vol 1. London: WB Saunders; 1997.
5. Bousser MG, RRR. Cerebral Venous Thrombosis, vol 1. London: WB Saunders; 1999.
6. Kosinski CM, MM, Schwarz M, et al. Do normal D-dimer levels reliably exclude cerebral sinus thrombosis? Stroke. 2004;35:2820-2825.
7. Casey SO, AR, et al. Cerebral CT venography. Radiology. 1996;198:163-170.
8. Ozsvath RR, CS, et al. Cerebral venography: comparison of CT and MR projection venography. AJR Am J Roentgenol. 1997;169:1699-1707.
9. Boggild MD, SR, Fraser D, et al. Cerebral venous sinus thrombosis and antiphospholipid antibodies. Postgrad Med. 1995;71:487-489.
10. Mokri B, JCJ, Petty GW. Pseudotumor syndrome associated with cerebral venous sinus occlusion and antiphospholipid antibodies. Stroke. 24:469-472.
11. Levine SR, KS, Puzio K, et al. Cerebral venous thrombosis with lupus anticoagulants: report of two cases. Stroke. 1987;18:801-804.
12. Deschiens M-A, Horellou MH, Alain A, et al. Coagulation studies, factor V Leiden, and anticardiolipin antibodies in 40 cerebral venous thrombosis. Stroke. 1996;27:1724-1730.
13. Heistinger M, RE, Illiasch H, et al. Cerebral sinus thrombosis in a patient with hereditary protein S deficiency: case report and review of the literature. Ann Hematol. 1992;64:105-109.
14. Prats JM, GC, Zuavo E, et al. Superior sagittal sinus thrombosis in a child with protein S deficiency. Neurology. 1992;42:2303-2305.
15. Cros D, CP, Beltramn G, et al. Superior sagittal sinus thrombosis in a patient with protein S deficiency. Stroke. 1990;21:633-636.
16. Ludemann P, DGN, Junker R, et al. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis. Stroke. 1998;29:2507-2510.
17. Einhaupl KM, VA, Meister W, et al. Heparin treatment in sinus venous thrombosis. Lancet. 1991;338:597-600.
18. de Bruijn SFTM, SJ. Randomized, placebo control trial of anticoagulation treatment with low-molecular weight heparin for cerebral sinus thrombosis. Stroke. 1999;30:484-494.
19. Lesing AWA, PM, Davidson BL, et al. Treatment of deep venous thrombosis with low molecular weight heparin: a meta-analysis. Arch Intern Med. 1995;155:601-662.
20. Vines FS, DD. Clinical radiological correlation in cerebral venous occlusive disease. Radiology. 1971;98:9-22.
21. Horowitz M, PP, Unwin H, et al. Treatment of dural sinus thrombosis using selective catheterization and urokinase. Ann Neurol. 1995;38:58-67.
22. Frey JL, HS, Dean BL, et al. Intrathrombus administration of rt-PA in intracranial thrombosis. Neurology. 1996;46(suppl):255:Abstract P03.099.
23. Kim SY, SJ. Direct endovascular thrombolytic therapy for dural sinus thrombosis: infusion of alteplase. AJNR Am J Neuroradiol. 1997;18:639-645.
24. Wasay M, RM, Kojan S, et al. Nonrandomized comparison of local urokinase thrombolysis versus systemic heparin anticoagulation for superior sinus thrombosis. Stroke. 2001;32:2310-2317.
25. Ferro JMM, Canhao P, Stam J, et al. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke. 2004;335:664-670.
26. Ferro JM, CM, Rosas MJ, et al. Seizures in cerebral vein and dural sinus thrombosis. Cerebrovasc Dis. 2003;15:78-83.
27. Biousse V, BM. Cerebral venous thrombosis. Neurologist. 1999;5:326-349.
28. Diaz JM, SJ, Urban ES, et al. Superior sagittal sinus thrombosis and pulmonary embolism: a syndrome rediscovered. Acta Neurol Scand. 1992;86:390-396.
29. Girolami A, RA, Gerosa M, et al. Further studies on clotting changes in patients with cerebral sinus thrombosis. A case with thrombosis of right transverse sinus. Folia Haematol Int Mag Klin Morphol Blutforsch. 1981;108:597-604.
30. Mehraein S, OH, Busch M, et al. Risk of recurrence of cerebral venous and sinus thrombosis during subsequent pregnancy and puerperium. J Neurol Neurosurg Psychiatry. 2003;74:814-816.